CIK 0001422143
- Non-accelerated filer
- Smaller reporting company
Kura Oncology, Inc.
Sign in to watch- Ticker
- KURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 611547851
- Phone
- +1 858-500-8800
- Business address
- 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
- Former names
- ZETA ACQUISITION CORP III
- Open-market buys, last 90 days
- $4,248,530
- in 3 filings
- Open-market sales, last 90 days
- $1,310,361
- in 7 filings, $252K under 10b5-1 plans
Net +$2,938,169. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- WILSON TROY EDWARD +$4.2M President and CEO 3 filings
- Leoni Mollie −$440K Chief Medical Officer sold 23% of stake
- Powl Brian T. −$397K Chief Commercial Officer sold 21% of stake
- Burrows Francis −$225K Chief Scientific Officer sold 33% of stake
- FORD KATHLEEN −$112K Chief Operating Officer sold 7% of stake
Reading 38 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-25 | Hasnain Faheem Director | Grant or award · Option to purchase common stock | +13,000 | 13,000 | ||
| 2019-06-25 | HOFFMAN ROBERT Director | Grant or award · Option to purchase common stock | +13,000 | 13,000 | ||
| 2019-01-22 | REN PINGDA SVP Chemistry&Pharma Sciences | Grant or award · Option to purchase common stock | +75,000 | 75,000 | ||
| 2019-01-22 | North Annette SVP, General Counsel | Grant or award · Option to purchase common stock | +100,000 | 100,000 | ||
| 2019-01-22 | FARNAM JOHN Chief Operating Officer | Grant or award · Option to purchase common stock | +125,000 | 125,000 | ||
| 2019-01-22 | GRASSO MARC CFO, CBO | Grant or award · Option to purchase common stock | +140,000 | 140,000 | ||
| 2019-01-22 | GUALBERTO ANTONIO Head of Development & CMO | Grant or award · Option to purchase common stock | +140,000 | 140,000 | ||
| 2019-01-22 | WILSON TROY EDWARD President and CEO | Grant or award · Option to purchase common stock | +220,000 | 220,000 | ||
| 2018-12-21 | EcoR1 Capital Fund Qualified, L.P. 10% owner | Purchase | +83,540 | $13.16 | $1.1M | 4,408,097 |
| 2018-12-19 | EcoR1 Capital Fund Qualified, L.P. 10% owner | Purchase | +51,879 | $13.84 | $718K | 4,324,557 |
| 2018-12-18 | EcoR1 Capital Fund Qualified, L.P. 10% owner | Purchase | +78,469 | $13.82 | $1.1M | 4,272,678 |
| 2018-12-17 | EcoR1 Capital Fund Qualified, L.P. 10% owner | Sale | −26,520 | $13.20 | $350K | 4,194,209 |
| 2018-12-13 | EcoR1 Capital Fund Qualified, L.P. 10% owner | Purchase | +25,217 | $13.89 | $350K | 4,220,729 |
| 2018-12-11 | EcoR1 Capital Fund Qualified, L.P. 10% owner | Purchase | +15,321 | $13.91 | $213K | 4,195,512 |
| 2018-12-06 | EcoR1 Capital Fund Qualified, L.P. 10% owner | Purchase | +17,079 | $13.49 | $230K | 4,180,919 |
| 2018-12-04 | EcoR1 Capital Fund Qualified, L.P. 10% owner | Purchase | +54,645 | $13.08 | $715K | 4,163,112 |
| 2018-12-03 | EcoR1 Capital Fund Qualified, L.P. 10% owner | Purchase | +48,182 | $13.97 | $673K | 4,108,467 |
| 2018-11-06 | WILSON TROY EDWARD President and CEO | Exercise or conversion | +26,041 | $4.80 | $125K | 59,026 |
| 2018-11-06 | WILSON TROY EDWARD President and CEO | Exercise or conversion · Option to purchase common stock | −26,041 | 65,974 | ||
| 2018-11-06 | Szela Mary T Director | Grant or award · Option to purchase common stock | +30,000 | 30,000 |
Page 18 of 19 · 366 trades